Investors

|

Portal
Order
Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

Innovation

Publications

Back

Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

– Caris Life Sciences

Poster

Background

A great need exists for new therapeutic approaches for patients with pancreatic cancer

Download Publication

Discover
More

  • Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer

    – Caris Life Sciences

    Manuscript

    Abstract Background: Prostate-specific membrane antigen (PSMA; FOLH1) is a cell-surface target for diagnostics and treatment in prostate cancer. We utilized a database of molecularly-profiled prostate tumors… […]

  • Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence

    – Caris Life Sciences

    Manuscript

    Abstract Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often… […]
Learn More

Ready to Get Started on the Journey?